Ppt Of Mnyl
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Ppt Of Mnyl as PDF for free.
More details
- Words: 4,193
- Pages: 48
Max India Limited Investor Presentation
Disclaimer This presentation may contain statements that are forward looking. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors listed in the management discussion and analysis section of our Annual Report. We do not undertake any responsibility to update any forward looking statements nor should this be constituted as a guidance of future performance. 1
Max India – An Introduction Max India Limited is a multi-business corporate, driven by the spirit of Enterprise, focused on Knowledge, People and Service oriented businesses of Life Insurance, Healthcare and Clinical Research. Max also maintains interests in Speciality Plastic Products for the packaging industry and Healthcare Staffing.
Core
Others
MISSION
VISION “To be one of India’s Most Admired Corporates for Service Excellence”
n
n
n n n
Establish niche service businesses in Life Insurance, Healthcare and Clinical Research Life Insurance and Healthcare……..convergence! Rank amongst top 3 players in each niche Partner with best-in-class world leaders Create service excellence in all businesses
www.maxindia.com BSE Scrip Code: 500271, NSE Ticker: Max, Bloomberg: Max IN
2
Max India – Life ….. Our Focus
Protecting Life through Life Insurance
www.maxnewyorklife.com
Caring for Life through Healthcare
www.maxhealthcare.in
Improving Life through Clinical Research
www.neeman-medical.com
3
Track record of successful international Business Partnerships…over last 20 years Gist Brocades, The Netherlands
Pharmaceuticals Pharmaceuticals
Motorola, USA
Electronic Electronic Component Component Distribution Distribution
Mobile Mobile Telephony Telephony
Communication Communication Services Services
Plating Plating Chemicals Chemicals
Medical Medical Transcription Transcription
Avnet Inc, USA
Hutchison COMSAT
Hutchison Telecommunication Ltd, Hong Kong Comsat Investment Inc Lockheed Martin Global Telecommunications, USA
ATOTECH
Schering AG, Germany Atotech Deutschland GmbH, Germany Healthscribe Inc., USA
4
Max India – Key Financial Indicators (FY 05 – 06) n
Revenue
Profitability
Investments
Reserves
Consolidated revenue at $342 Million Life Insurance revenue at $189 Million Up 96% Healthcare revenue at $31 Million Up 195%
n
Consolidated cash generated from operations at $57 Million Up 395%
n
Group Assets Under Management at $304 Million Up 122%
n
Max Telecom Ventures merges with Max India Ltd., post merger reserves of Max India at $205 Million Max India - Share Price Trend
Share Price and Capitalization
1000 800 600
n
Current share price is over Rs. 1000 ($22)
400 200
n
Market capitalization is over $800 Million
0 Mar- Jun- Sep- Dec- Mar- Jun- Sep- Dec- Mar- Jun- Sep- Dec04 04 04 04 05 05 05 05 06 06 06 06
5
Max India – Balance Sheet* Sources of Funds
US$ Million
Reserves – 216
Application of Funds Share Capital – 8
Loan Funds – 51
Business Investments – 164
Fixed Assets – 25
Net Current Assets – 11
*As at December 31, 2006
Cash and Liquid Investments – 75
6
Investment in Core Businesses US $ Mn
Business
Current Equity Peak Equity Planned Investment Investment outlay for the business by Max India by Max India
Life Insurance *
222
115
164
Healthcare #
156
37
60
Current stake of Max India *
Life Insurance – 74%
#
Healthcare – 73% 7
Max India – Shareholding Pattern Number of Outstanding Shares as on December 31, 2006 – 35,980,411 Promoter Group – Analjit Singh 41%
FDI – Warburg Pincus 17%
Others 17% FII – Others 14%
FII – Warburg Pincus 11%
8
Max India Board Recommends Stock Split One Equity Share of par value Rs. 10/each to be split into 5 Equity Shares of par value Rs. 2/- each
Shareholder’s Extra-ordinary General Meeting for approval on February 26, 2007 9
Max India – Board of Directors Mr. Analjit Singh – Chairman Dr. S.S. Baijal Mr. N.C. Singhal Mr. Ashwani Windlass Mr. Bharat Sahgal Mr. N. Rangachary Mr. Piyush Mankad Mr. Rajesh Khanna – Warburg Pincus Mr. B. Anantharaman – Joint Managing Director 10
Max Healthcare
www.maxhealthcare.in 11
Max Healthcare Model
Tertiary
Secondary
Primary
n n
n n
n
Heart & Vascular Institute Super Speciality Hospital
Heart and Vascular Neurosciences Joint Replacement & Orthopaedics Obstetrics and Gynaecology Paediatrics
Hospitals – 4 Speciality Centres – 2
Surgery and inpatient facilities High-end Diagnostics: MRI, CT Doctor Consultation Eye and Dental Care
Clinics/Implants – 9
Specialist doctor consultation and a full time nurse. Basic diagnostics like Pathology Collection
Enable retention of patient traffic Enable ‘start-to-finish’ comprehensive, seamless care: Consult and Diagnostics, Diagnostic tests, pre-operative work up, operations, post-operative care 12
Vision – Mission PASSION
Key Differentiators
Focused NCR centric delivery – for operational excellence
Close to customer – geography
Comprehensiveness of medical services (except organ transplant and radio
VISION • • • • • •
therapy)
Leadership in 5 super-specialties in tertiary care
Ethics
Memorable brand experience
-‘Star’ physicians supported by a group of high quality physicians
MISSION
-‘Star’ and quality physicians -Infrastructure and equipment
GOALS
-No surprises – cost of care, pricing, medication -Signage -Look – feel – smell - touch
KEY
Innovation to bring in walk-in customers
OBJECTIVES
-Location location -Max Health Plan under roll-out -Other new programs ie Golden Years, Life Membership, Prepaid
High quality nursing and paramedic care supported
Technology and IT (in 18 months)
Extensive emphasis on training
STRATEGIES
Medical Excellence Service Excellence – Total Experience
In your community - near you
High-end tertiary care in Private sector
Comprehensiveness
Referral system – National &
Value for money
Partnering with medical community
Caring place to work
Corporate Social Responsibility
International
Profitable without profiteering. Seamless linkage between secondary and tertiary care. Innovate to address wider market.
WHAT – Medical USP’s ; Best in class ; Comprehensive care ; Convenience & accessibility ; Seamless service ; Patient records ; Consistent and customised care ; Service excellence ; Preventive health ; Caring place to work.
HOW – Train train train ; Partnership with Medical community ; Principal choice for physicians ; Never ending focus on medical and service excellence ; Build lasting customer relationships ; Primary, Secondary and Tertiary care through Co. managed / partnership; No franchising. • Shared responsibility with single accountability. • Unique approach through: - International benchmarking. - Walk the Talk - IT Capability - Medical – Management Alignment. - Rehearse rehearse - Cost Efficiency - Train train train. - Mystery customers - Attrition Management
INITIATIVES
Key Public Messages
Create unparalleled standards of Medical & Service Excellence Care provider of FIRST CHOICE Principal Choice for Physicians Ethical Practices Create National Centre of Excellence for select Super Specialties. Build towards international ‘reach’ by creating patient confidence through professional skills, research and technology
• WHAT- HOW - WHEN - COST - LINKAGE
by nursing and paramedic college
• • •
Build Trust
Deliver world class healthcare with a service focus, by creating an institution committed to the highest standards of medical & service excellence, patient care, scientific knowledge and medical education.
VALUES & BELIEFS • Caring • Excellence • Integrity - Personal - Professional • Openness/Transparency • Teamwork • Knowledge • Win-win partnerships
OPERATING PRINCIPLES • • • • • • • • •
Courtesy & Caring always Customer comes first Do it right first time International image standards Efficient process management Direct & open communications Create trust Fun at work Compliance
METRICS & STANDARDS • ISO 9001 : 2000 • JCIA Accreditation • Credentialing / Grant of privileges • Employee productivity • Employee Engagement survey • Service Dashboard - Sparsh • NABH Accreditation • NABL certified Lab system.
PERFORMANCE MGMT PROCESS • • • • •
Competence rating Potential analysis PSC model Balanced scorecard Performance / Risk linked reward.
13
Max Healthcare – Board of Directors Mr. Analjit Singh
Chairman and Managing Director
Mr. B Anantharaman
Joint Managing Director, Max India Limited
Dr. Ashok Seth Mr. KK Mathur Dr. RP Soonawala Mr. Aman Mehta Mr. Anuroop Tony Singh Mr. Rajesh Khanna
Warburg Pincus 14
Indian Healthcare Indian Healthcare Industry: n
Indian healthcare industry – Currently estimated at about $33 Billion Growing at 12% to 15% per annum Expected to be over $65 – 70 Billion by 2012, mainly driven by private sector investments
n
Over 1 Billion people, spread across different economic classes
n
Target Segment – More than 200 million upper and middle class Growing at over 4% per annum, with combined annual income of over $182 Billion
Health expenditure in India by funding sources:
Government 25%
Majority of healthcare spending in India is on self pay… Self-pay 59%
Municipal Bodies 8%
Employers 6%
Foreign Aid 2%
15
Current Facilities
16
Current Facilities MAX HEART AND VASCULAR INSTITUTE – SAKET [South Delhi] n
250 patient beds
n
3 Operation Theatres, 2 Cardiac Catheterization Labs
n
Total covered area of approx.150000 sq. ft.
n
Post Surgery Critical Care Unit
n
High Dependency Unit
n
Apex Coronary Care
n
Advanced Coronary Care Unit
n
Exclusive well equipped ‘Observation Bay’ and ‘Post Cath. Recovery’
n
Nuclear Diagnostic Services with Variable Angle Dual Head Gamma Camera
n
Centralized Emergency Command with Advanced Cardiac Life Support Ambulances and Air Evacuation Service.
n
Max Institute of Allied Medical Sciences (High-end General Surgery)
Operational since January 2005 17
Current Facilities MAX SUPER SPECIALITY HOSPITAL – SAKET [South Delhi] n
225 beds (including 70 critical care beds)
n
To include: 7 OTs, 20 Consult Chambers Tower Specialties – Orthopaedics, Neuro Sciences, Obstetrics & Gynaecology and Paediatrics Brain Suite (first operative MRI
in
Asia)
and
intra
DSA Lab (for Neuro Sciences) Emergency Services High end Radiology facilities with 64 slice Cardiac CT
Operational since June 2006 18
Current Facilities SECONDARY CARE MAX HOSPITALS OPERATIONAL AT…
PITAMPURA (February 2002) (North Delhi)
NOIDA (August 2002) (Suburb)
PATPARGANJ (May 2005) (East Delhi)
100 inpatient beds 2+1 OT, 1 LR Lithotripsy Mother & Child care Non-Invasive Cardiology Plastic and Reconstructive surgery Physiotherapy Full range diagnostics PHP, OPD and Dentistry
40 inpatient beds 2+1 OT, 1 LR Mother & Child care Non-Invasive Cardiology Laparoscopic Surgery Orthopaedics ENT, Ophthalmology Urology & Nephrology Full range diagnostics PHP, OPD and Dentistry
145 inpatient beds 2+1 OT Mother and Child care Orthopaedics General Surgery Critical care incl. Dialysis Non-invasive Cardiology (incl. Cardiac Catheterization Lab) ENT, Ophthalmology Other allied specialties 19
Current Facilities SPECIALITY CENTRES – PANCHSHEEL [South Delhi]
OPTHALMOLOGY AND DENTAL CARE (November 2005) Lasik, OPD and Diagnostics Dental – 3 chambers, OPG and Lab Support Services and Offices (N & S)
SPECIALIST CONSULTS & HIGH-END DIAGNOSTICS (August 2006)
GP & Specialist Consults Full Diagnostics (incl. MRI/CT) Neurology (EEG and EMG) Preventive Health and Chronic Care Physiotherapy Minor Procedures and Emergencies 20
Fact Sheet Revenue (9M’FY07) Occupancy Employees Physicians Corporate Clients Patient Base Patient Transactions Beds ICU Beds OTs Cathlabs MRIs CTs
US$ 39 Mn, 90% y-o-y growth 59% (quarter ended Dec’06) 2100 1000 (includes over 350 on Rolls) 425 Over 400,000 Over 100,000 per month 850 200 21 3 4 5
Medical/Clinical Collaboration with Singapore General Hospital 21
Upcoming Facilities
22
Upcoming Facilities n
Max Hospital – Gurgaon n
100 bed Hospital with 2 OTs
n
Tower Specialties to include: Ophthalmology (Anterior and Posterior) Woman & Child (including Infertility) Orthopaedics Nephrology and Urology Plastic and Reconstructive Surgeries General and Minimally Invasive surgeries Launch by June 2007
n
Clinics & Referral tie-ups at key locations for patient flow into hospitals
9 Centres in and around Delhi/NCR by 2009 with a capacity of 1500-1600 beds 23
Second Phase of Expansion NCR
Outside NCR
Max Balaji Hospital – Patparganj Tertiary Care
Max Hospital – Dehradun High-end Secondary Care
n
n
250-300 Inpatient beds with 6 OTs and 1 Cathlab – Before end of 2008 Tower specialties to include: Oncology IVF Orthopaedics & Joint Replacement Neurosciences Cardiac Care Critical Care
n n n n n
100 Inpatient beds – Before end of 2008 Emergency & Trauma care Non–invasive Cardiology Joint Replacement & Orthopaedics MIS All support Specialities
Max Hospital – Saket South Block Tertiary Care n n n
85 Inpatient beds with 2 OTs – April 2009 Obstetrics & Gynaecology Paediatrics 24
Max Healthcare – Outlook Revenue 152 141 126
US $ Million
98 77 54 30 11
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
Cash Breakeven by FY 09 25
Max Healthcare Project Cost and Funding Phase – 1
Equity US$ 95 million
n
Max India – Promoters Current – $37 Mn Future – $23 Mn
n
Warburg Pincus – $31 Mn
n
Other Foreign Investors – $4 Mn
Project Cost US$ 156 million Debt US$ 61 million
n
HDFC – $23 Mn
n
Other Indian Banks and Financial Institutions – $38 Mn
Debt – Equity Ratio: 0.64
Second Phase of Expansion to cost US$ 45 Mn 26
Max New York Life Insurance
www.maxnewyorklife.com 27
Max New York Life Insurance [ MNYL] n
Joint Venture between Max India and New York Life International [ NYL ]
n
NYL, one of Fortune 100 companies provides insurance domain expertise
n
NYL is one of the oldest mutual life insurance company in the US with over $200 billion in assets under management
n
Max India contributes local market understanding and managing regulatory environment
n
Robust business performance – Peak equity investment to be $222 Mn
28
MNYL road map to becoming India’s most admired Life Insurance Company Key Public Messages
VISION
A trusted life insurance specialist Customer centric Financially responsible and strong A great place to work An admired member of the community
MISSION
Key Differentiators
Financial Strength & Security Quality of agents Flexible Products Service Excellence Fair Terms of Business
GOALS
KEY OBJECTIVES
STRATEGIES
Part of top quartile new Life Insurance Companies National Player Brand of FIRST choice Employer of Choice Principal of Choice for Agents
1 Billion $ in Premiums in 10th year IRR–20% plus; Dominate MDRT in India; Profitable by 2008 WHAT – Comprehensive suite of products, competitive pricing, extensive distribution, persistency, customer service excellence, profitable portfolios HOW – Talented People, Professional & Productive Agents, Performance Metrics, Leverage Technology, Teamwork, Customer Centric, Innovative Distribution and Marketing What-When-Who-How-Cost linkage plans at Departmental and Individual levels
INITIATIVES VALUES & BELIEFS
Excellence Caring Integrity Honesty Knowledge Teamwork
Become the most admired Life Insurance Company in India
OPERATING PRINCIPLES
Customer comes first International quality standards Do it right the first time Fact based decisions Bias for result oriented action Financial strength & discipline Direct and open communication Respect Max & NYLI values & parentage Fun at work
METRICS & STANDARDS
Input Output External Internal Absolute Ratios
PERFORMANCE MGMT PROCESS GMPR Ratings TEC/TTR – Templates Primary, Shared and Contributory Balanced scorecard Core, Functional and Leadership Competencies
29
MNYL – Board of Directors Mr. Analjit Singh
Chairman
Mr. B Anantharaman
Joint Managing Director, Max India Limited
Mr. N. C. Singhal Mr. Rajesh Khanna
Warburg Pincus
Mr. Joseph Gilmour Mr. Fred Sievert Mr. Anuroop Tony Singh Mr. Ravi Akhoury Mr. Gary R. Bennett
Chief Executive Officer & Managing Director
Mr. Sunil Sharma
Executive Director & Chief Operating Officer 30
Indian Life Insurance Industry An Opportunity Strong Growth to be driven by…
11.2
Life insurance premium as % of GDP 8.3 8.6
8.9
7.1 7.3
Low Penetration Level
Premium per capita ($) adjusted for PPP 2,337
Taiwan
UK
Hong Kong
Japan
South Korea
France
Singapore
4.1
United States
Malaysia
Better Distribution
3.5 3.6
Australia
n
3.1
Germany
Increasing Awareness
2.5
India
n
1.8 2.0
Thailand
Increasing Per Capita Income
1.3
Brazil
n
6.0
China
n
2,798
2,471
2,079 1,6721,677 1,732
n
1,343
Availability of Multiple Products
883
UK
Hong Kong
Japan
France
Singapore
United States
South Korea
Australia
Germany
Malaysia
Brazil
Increased Life Expectancy
115 143
China
n
88
India
411
Strong GDP growth to further expand the industry potential 31
MNYL’S Strategy to build a Strong Life Insurance Business 1)
Full Suite of products with a focus on protection n Long Tenor products (Average Tenure – 25), Young customer base (Average Age – 34) n Unit Link contributes over 67% of total sales of the Company for the period Jan’06 – Dec’06 rd amongst private players in terms of number of policies sold n Ranks 3 Sold over 1.3 Mn policies since inception
2)
Build best in class agency
3)
n
Productivity higher than the competition
n
Comprehensive in-house training (over 200 trainers)
n
Over 400 hours of training
n
Amongst top global MDRT in 2006 with around 350 agents qualifying for the league
Wide geographic coverage n
132 offices across 94 locations
n
121 new agency offices planned by 2008
n
Multi-level marketing alliances continues to perform well… working at over 300 locations
n
MNYL to focus on developing alternate distribution channels having wide reach and deep-rooted distribution network
n
Partnership with 17 banks, current access covers 450+ branches across 50+ locations 32
MNYL’S Strategy to build a Strong Life Insurance Business 4)
Among the top private Indian life insurers with paid up capital base of $157 Mn
5)
Strong quality orientations to business
6)
n
First life insurer to be awarded the ISO 9000 : 2001 certification
n
6 sigma program underway
n
Balanced scorecard approach
n
Good Audit & Compliance orientation
Strong customer trust and credibility n Balanced investment approach with a very long term view 64% of traditional portfolio consists of long tenor government paper 29% in AA+ and better corporate bonds
7)
n
Equity portfolio performance better than the benchmark*
n
No asterisks in advertising
n
Honest illustration Controlled centrally Sent along with policy
High embedded value / appraisal value creation
*Benchmark Index: CNX 500
33
Protection Oriented, Longer Tenor Life Insurance PRODUCT TYPE
PROPORTION OF POLICIES (%, by number)
Tenure (Years)
Age of Insured (Years)
40
WHOLE LIFE
25
ENDOWMENT
18
TERM
4
DEFERRED ANNUITY
1
17
MONEY BACK
22
12
UNIT LINKED
30
24
26
22
37
42
37
23
35
25 As on Dec 31, 2006
36
MNYL Average
34 MNYL Average
34
Market Position – 2006-07 Insurance Sales (US $ Mn) Company ICICI Prudential Bajaj Allianz HDFC Standard Life SBI Life Max New York Life Aviva Birla Sunlife Tata AIG Reliance Life All Others
Individual New Business Premium (Apr'06-Dec'06) 511 321 168 134 117 5 93 93 80 74
166
Policies (‘000) (Apr'06-Dec'06) 1145 928 284 293 386 3 188 208 283 220 361
Total Private Life Insurers
1757
4296
MS of Private Players (%)
30
22
Source: Insurance Regulatory & Development Authority, Adjusted to include only 10% of Single Premium All Others include: Kotak Life, ING Vysya, Metlife, Shriram Life, Sahara, Bharti AXA, 1 US$ = Rupees 45
35
Established Ourselves amongst the Leading Agency Sales Force Adjusted Single premium
New Business Apr - Dec 2006 (Agency) (US$ Mn)
Agents
Premium per Agent * ($)
Cases per Agent *
358
130,000
306
0.8
209
109,000
213
0.7
17,490
590
92
65,000
158
0.3
67
25,000
297
0.6
62
30,000
232
0.7
46
11,000
466
1.1
45
12,500
404
0.7
39
21,500
202
0.4
36
35,000
114
0.4
33
14,000
260
0.5
15
10,000
169
0.3
93
Rank 3
Rank 1
1.6 Rank 1
* In terms of highest new business premium (Agency) Source: IRDA Journal, media reports and team inputs
36
MNYL Footprint 31 Offices
Wide Reach Established
Dedicated to Rural Business
Punjab HO Chandigarh Dehradun Gurgaon Faridabad Delhi Jaipur Noida Dehradun Meerut Jodhpur Karnal Udaipur Kanpur Lucknow Gwalior
Siliguri Guwhati
Varanasi Ahmedabad Patna Bhopal Rajkot Baroda Asansol Jamshedpur Indore Bhavnagar Kolkata Ranchi Surat Nagpur Vapi Mumbai Kohlapur Bhubaneswar Nasik Aurangabad Raipur Thane Hyderabad Pune
Rajahmundry Visakhapatnam Vijaywada
Panaji Bangalore
Chennai
Actual customer base spread over 200 cities
Cities Own
Offices
87
122
7
10
94
132
Mangalore
Franchisees Coimbatore Madurai Cochin
Overall Presence
Trivandrum
37
Max New York Life Insurance Key Business Drivers a) Sales Value (Annualized first year premium)
Unit US$ Mn
Quarter Ended Dec-06 Dec-05
Year Ended Dec-06 Dec-05
YoY Growth
66.30
36.64
186.47
95.08
96%
b) Average case size
US$
570
369
452
349
30%
c) Case rate per agent per month
No.
1.68
2.29
1.76
1.84
-5%
d) Number of agents
No.
20,987
13,476
56%
e) Net agents added
No.
7,511
6,568
f) Conservation ratio
%
80.06%
80.41%
147.43 109.00 24.78 281.20
75.79 60.36 6.08 142.23
95% 81% 308% 98%
2,205
1,274
g) Gross written premium income First year premium Renewal premium Single premium Total
US$ Mn
h) Paid up Capital
US$ Mn
146.10
117.20
25%
No.
958,229
607,652
58%
8,215
5,227
57%
i) Individual Policies in force j) Sum insured in force
50.05 37.67 12.64 100.35
US$ Mn
23.96 22.05 4.59 50.61
38
Neeman Medical International
www.neeman-medical.com 39
Neeman Medical International Contract Research Organization (CRO) Neeman Medical International is a value added Clinical Research Service Organization. Neeman’s goal is to provide highly competent GCP/ICH compliant Investigators in several geographies, who have access to patients and dedicated Clinical Research Coordinators. This allows Neeman to accelerate patient enrollment and generate high quality data
Neeman Medical International – Service offerings include n
Site Management
n
Project Management
n
Data Management, includes Bio-Statistics and Report Writing
n
Monitoring Services
n
Clinical Trial Material Supply Chain Management Services
40
Neeman Medical International Business Highlights n
6 out of top 10 pharma companies are Neeman’s customers Phase – IV award in the Data Management space from one of the top 3 pharma majors.
n
Discussions underway with pharma majors for making Neeman a preferred service provider Preferred provider relationship with 3 Pharma majors in place
n
Alliances with CROs in Europe for business expansion
n
Client base doubles up from 14 to 28
n
Number of awards swell 177 % from 22 in previous year to 61 up to Dec’ 06
n
Order Book pipeline of over $6.5 Million
n
Network of 600 GCP/ICH Principal Investigators with access to 25,000 beds and 6-8 million patients
n
Impressive operating standards Successfully completed 4th US FDA-GCP audit for highest enrollments Patient retention rate continues to be over 98%
n
Favorable Patent Regulations in India to catalyze exponential growth 41
Neeman – Select List of Partners
42
Max HealthStaff International
www.maxhealthstaff.com 43
Max HealthStaff International Max HealthStaff International Limited is an international healthcare staffing company, founded on world-class quality and service excellence. It is committed to becoming India's leading healthcare staffing company, offering professionals to healthcare institutions in India and abroad. Big Gap in Demand/Supply of Healthcare Resources in US, particularly nurses…projected to increase further US Supply and Demand Projections for Registered Nurses 2000 to 2020
Current Shortage of Nurses: 200,000 Increasing every year – Expected to be over 400,000 by 2008 and 850,000 by 2020 Shortage of allied healthcare staffing resources such as occupational and physical therapists, pharmacists, radiographers etc. estimated to be more than 360,000 by 2008 44
Max HealthStaff International n
First of its kind large scale corporate business initiative in India for providing end to end placement solutions. Has begun placement of nursing staff, will soon expand into other allied healthcare resources
n
Annuity based revenue model with cash inflows expected for periods upto 36 months for each placed candidate
n
6 Sourcing and Training Centers across Delhi, Chandigarh and Kerala Chennai sourcing and training centre to commence operations soon
n
Customer Profile Leading Healthcare staffing companies, including publicly listed companies in US Non-exclusive contracts provides sufficient operational and strategic flexibility to the business
n
50 Nurses already placed in the US – Established proof of concept
n
Over 600 nurses in pipeline… growing rapidly Over 100 NCLEX-RN cleared nurses in the pipeline NCLEX results at 85% – best in the Industry
n
Monthly revenue rate of USD 60k…expected to grow continuously
n
Currently focusing on US, will expand to Middle East shortly 45
Max Speciality Products
46
Max Speciality Products Manufacturer / Supplier of Niche Speciality polymer films. n n n n n
n
(high contribution)
and
High
Barrier
Capture value by producing Value Added products Long term relationship with Blue chip customers in FMCG sector Pioneer in introduction of new products / technology in India Has a footprint in select export markets Industry CAGR of 20%
Generates revenue of $30 Mn and PBT of $2Mn for FY 05-06 Revenue from BOPP business at $28 Mn, grows 7% Revenue from MaxFoils at $2 Mn, grows 42%
n
EBITDA to net sales at 14%
n
Expansion Underway… 3rd Metalliser commissioned ahead of schedule in August’06, currently running at 80% capacity New BOPP capacity expansion – 20,000 TPA in advanced stage of implementation and currently on schedule – to be operational in first quarter FY07-08 Expansion to cost $27 Mn…Funded 66% through debt 47
Thank You
48
Disclaimer This presentation may contain statements that are forward looking. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors listed in the management discussion and analysis section of our Annual Report. We do not undertake any responsibility to update any forward looking statements nor should this be constituted as a guidance of future performance. 1
Max India – An Introduction Max India Limited is a multi-business corporate, driven by the spirit of Enterprise, focused on Knowledge, People and Service oriented businesses of Life Insurance, Healthcare and Clinical Research. Max also maintains interests in Speciality Plastic Products for the packaging industry and Healthcare Staffing.
Core
Others
MISSION
VISION “To be one of India’s Most Admired Corporates for Service Excellence”
n
n
n n n
Establish niche service businesses in Life Insurance, Healthcare and Clinical Research Life Insurance and Healthcare……..convergence! Rank amongst top 3 players in each niche Partner with best-in-class world leaders Create service excellence in all businesses
www.maxindia.com BSE Scrip Code: 500271, NSE Ticker: Max, Bloomberg: Max IN
2
Max India – Life ….. Our Focus
Protecting Life through Life Insurance
www.maxnewyorklife.com
Caring for Life through Healthcare
www.maxhealthcare.in
Improving Life through Clinical Research
www.neeman-medical.com
3
Track record of successful international Business Partnerships…over last 20 years Gist Brocades, The Netherlands
Pharmaceuticals Pharmaceuticals
Motorola, USA
Electronic Electronic Component Component Distribution Distribution
Mobile Mobile Telephony Telephony
Communication Communication Services Services
Plating Plating Chemicals Chemicals
Medical Medical Transcription Transcription
Avnet Inc, USA
Hutchison COMSAT
Hutchison Telecommunication Ltd, Hong Kong Comsat Investment Inc Lockheed Martin Global Telecommunications, USA
ATOTECH
Schering AG, Germany Atotech Deutschland GmbH, Germany Healthscribe Inc., USA
4
Max India – Key Financial Indicators (FY 05 – 06) n
Revenue
Profitability
Investments
Reserves
Consolidated revenue at $342 Million Life Insurance revenue at $189 Million Up 96% Healthcare revenue at $31 Million Up 195%
n
Consolidated cash generated from operations at $57 Million Up 395%
n
Group Assets Under Management at $304 Million Up 122%
n
Max Telecom Ventures merges with Max India Ltd., post merger reserves of Max India at $205 Million Max India - Share Price Trend
Share Price and Capitalization
1000 800 600
n
Current share price is over Rs. 1000 ($22)
400 200
n
Market capitalization is over $800 Million
0 Mar- Jun- Sep- Dec- Mar- Jun- Sep- Dec- Mar- Jun- Sep- Dec04 04 04 04 05 05 05 05 06 06 06 06
5
Max India – Balance Sheet* Sources of Funds
US$ Million
Reserves – 216
Application of Funds Share Capital – 8
Loan Funds – 51
Business Investments – 164
Fixed Assets – 25
Net Current Assets – 11
*As at December 31, 2006
Cash and Liquid Investments – 75
6
Investment in Core Businesses US $ Mn
Business
Current Equity Peak Equity Planned Investment Investment outlay for the business by Max India by Max India
Life Insurance *
222
115
164
Healthcare #
156
37
60
Current stake of Max India *
Life Insurance – 74%
#
Healthcare – 73% 7
Max India – Shareholding Pattern Number of Outstanding Shares as on December 31, 2006 – 35,980,411 Promoter Group – Analjit Singh 41%
FDI – Warburg Pincus 17%
Others 17% FII – Others 14%
FII – Warburg Pincus 11%
8
Max India Board Recommends Stock Split One Equity Share of par value Rs. 10/each to be split into 5 Equity Shares of par value Rs. 2/- each
Shareholder’s Extra-ordinary General Meeting for approval on February 26, 2007 9
Max India – Board of Directors Mr. Analjit Singh – Chairman Dr. S.S. Baijal Mr. N.C. Singhal Mr. Ashwani Windlass Mr. Bharat Sahgal Mr. N. Rangachary Mr. Piyush Mankad Mr. Rajesh Khanna – Warburg Pincus Mr. B. Anantharaman – Joint Managing Director 10
Max Healthcare
www.maxhealthcare.in 11
Max Healthcare Model
Tertiary
Secondary
Primary
n n
n n
n
Heart & Vascular Institute Super Speciality Hospital
Heart and Vascular Neurosciences Joint Replacement & Orthopaedics Obstetrics and Gynaecology Paediatrics
Hospitals – 4 Speciality Centres – 2
Surgery and inpatient facilities High-end Diagnostics: MRI, CT Doctor Consultation Eye and Dental Care
Clinics/Implants – 9
Specialist doctor consultation and a full time nurse. Basic diagnostics like Pathology Collection
Enable retention of patient traffic Enable ‘start-to-finish’ comprehensive, seamless care: Consult and Diagnostics, Diagnostic tests, pre-operative work up, operations, post-operative care 12
Vision – Mission PASSION
Key Differentiators
Focused NCR centric delivery – for operational excellence
Close to customer – geography
Comprehensiveness of medical services (except organ transplant and radio
VISION • • • • • •
therapy)
Leadership in 5 super-specialties in tertiary care
Ethics
Memorable brand experience
-‘Star’ physicians supported by a group of high quality physicians
MISSION
-‘Star’ and quality physicians -Infrastructure and equipment
GOALS
-No surprises – cost of care, pricing, medication -Signage -Look – feel – smell - touch
KEY
Innovation to bring in walk-in customers
OBJECTIVES
-Location location -Max Health Plan under roll-out -Other new programs ie Golden Years, Life Membership, Prepaid
High quality nursing and paramedic care supported
Technology and IT (in 18 months)
Extensive emphasis on training
STRATEGIES
Medical Excellence Service Excellence – Total Experience
In your community - near you
High-end tertiary care in Private sector
Comprehensiveness
Referral system – National &
Value for money
Partnering with medical community
Caring place to work
Corporate Social Responsibility
International
Profitable without profiteering. Seamless linkage between secondary and tertiary care. Innovate to address wider market.
WHAT – Medical USP’s ; Best in class ; Comprehensive care ; Convenience & accessibility ; Seamless service ; Patient records ; Consistent and customised care ; Service excellence ; Preventive health ; Caring place to work.
HOW – Train train train ; Partnership with Medical community ; Principal choice for physicians ; Never ending focus on medical and service excellence ; Build lasting customer relationships ; Primary, Secondary and Tertiary care through Co. managed / partnership; No franchising. • Shared responsibility with single accountability. • Unique approach through: - International benchmarking. - Walk the Talk - IT Capability - Medical – Management Alignment. - Rehearse rehearse - Cost Efficiency - Train train train. - Mystery customers - Attrition Management
INITIATIVES
Key Public Messages
Create unparalleled standards of Medical & Service Excellence Care provider of FIRST CHOICE Principal Choice for Physicians Ethical Practices Create National Centre of Excellence for select Super Specialties. Build towards international ‘reach’ by creating patient confidence through professional skills, research and technology
• WHAT- HOW - WHEN - COST - LINKAGE
by nursing and paramedic college
• • •
Build Trust
Deliver world class healthcare with a service focus, by creating an institution committed to the highest standards of medical & service excellence, patient care, scientific knowledge and medical education.
VALUES & BELIEFS • Caring • Excellence • Integrity - Personal - Professional • Openness/Transparency • Teamwork • Knowledge • Win-win partnerships
OPERATING PRINCIPLES • • • • • • • • •
Courtesy & Caring always Customer comes first Do it right first time International image standards Efficient process management Direct & open communications Create trust Fun at work Compliance
METRICS & STANDARDS • ISO 9001 : 2000 • JCIA Accreditation • Credentialing / Grant of privileges • Employee productivity • Employee Engagement survey • Service Dashboard - Sparsh • NABH Accreditation • NABL certified Lab system.
PERFORMANCE MGMT PROCESS • • • • •
Competence rating Potential analysis PSC model Balanced scorecard Performance / Risk linked reward.
13
Max Healthcare – Board of Directors Mr. Analjit Singh
Chairman and Managing Director
Mr. B Anantharaman
Joint Managing Director, Max India Limited
Dr. Ashok Seth Mr. KK Mathur Dr. RP Soonawala Mr. Aman Mehta Mr. Anuroop Tony Singh Mr. Rajesh Khanna
Warburg Pincus 14
Indian Healthcare Indian Healthcare Industry: n
Indian healthcare industry – Currently estimated at about $33 Billion Growing at 12% to 15% per annum Expected to be over $65 – 70 Billion by 2012, mainly driven by private sector investments
n
Over 1 Billion people, spread across different economic classes
n
Target Segment – More than 200 million upper and middle class Growing at over 4% per annum, with combined annual income of over $182 Billion
Health expenditure in India by funding sources:
Government 25%
Majority of healthcare spending in India is on self pay… Self-pay 59%
Municipal Bodies 8%
Employers 6%
Foreign Aid 2%
15
Current Facilities
16
Current Facilities MAX HEART AND VASCULAR INSTITUTE – SAKET [South Delhi] n
250 patient beds
n
3 Operation Theatres, 2 Cardiac Catheterization Labs
n
Total covered area of approx.150000 sq. ft.
n
Post Surgery Critical Care Unit
n
High Dependency Unit
n
Apex Coronary Care
n
Advanced Coronary Care Unit
n
Exclusive well equipped ‘Observation Bay’ and ‘Post Cath. Recovery’
n
Nuclear Diagnostic Services with Variable Angle Dual Head Gamma Camera
n
Centralized Emergency Command with Advanced Cardiac Life Support Ambulances and Air Evacuation Service.
n
Max Institute of Allied Medical Sciences (High-end General Surgery)
Operational since January 2005 17
Current Facilities MAX SUPER SPECIALITY HOSPITAL – SAKET [South Delhi] n
225 beds (including 70 critical care beds)
n
To include: 7 OTs, 20 Consult Chambers Tower Specialties – Orthopaedics, Neuro Sciences, Obstetrics & Gynaecology and Paediatrics Brain Suite (first operative MRI
in
Asia)
and
intra
DSA Lab (for Neuro Sciences) Emergency Services High end Radiology facilities with 64 slice Cardiac CT
Operational since June 2006 18
Current Facilities SECONDARY CARE MAX HOSPITALS OPERATIONAL AT…
PITAMPURA (February 2002) (North Delhi)
NOIDA (August 2002) (Suburb)
PATPARGANJ (May 2005) (East Delhi)
100 inpatient beds 2+1 OT, 1 LR Lithotripsy Mother & Child care Non-Invasive Cardiology Plastic and Reconstructive surgery Physiotherapy Full range diagnostics PHP, OPD and Dentistry
40 inpatient beds 2+1 OT, 1 LR Mother & Child care Non-Invasive Cardiology Laparoscopic Surgery Orthopaedics ENT, Ophthalmology Urology & Nephrology Full range diagnostics PHP, OPD and Dentistry
145 inpatient beds 2+1 OT Mother and Child care Orthopaedics General Surgery Critical care incl. Dialysis Non-invasive Cardiology (incl. Cardiac Catheterization Lab) ENT, Ophthalmology Other allied specialties 19
Current Facilities SPECIALITY CENTRES – PANCHSHEEL [South Delhi]
OPTHALMOLOGY AND DENTAL CARE (November 2005) Lasik, OPD and Diagnostics Dental – 3 chambers, OPG and Lab Support Services and Offices (N & S)
SPECIALIST CONSULTS & HIGH-END DIAGNOSTICS (August 2006)
GP & Specialist Consults Full Diagnostics (incl. MRI/CT) Neurology (EEG and EMG) Preventive Health and Chronic Care Physiotherapy Minor Procedures and Emergencies 20
Fact Sheet Revenue (9M’FY07) Occupancy Employees Physicians Corporate Clients Patient Base Patient Transactions Beds ICU Beds OTs Cathlabs MRIs CTs
US$ 39 Mn, 90% y-o-y growth 59% (quarter ended Dec’06) 2100 1000 (includes over 350 on Rolls) 425 Over 400,000 Over 100,000 per month 850 200 21 3 4 5
Medical/Clinical Collaboration with Singapore General Hospital 21
Upcoming Facilities
22
Upcoming Facilities n
Max Hospital – Gurgaon n
100 bed Hospital with 2 OTs
n
Tower Specialties to include: Ophthalmology (Anterior and Posterior) Woman & Child (including Infertility) Orthopaedics Nephrology and Urology Plastic and Reconstructive Surgeries General and Minimally Invasive surgeries Launch by June 2007
n
Clinics & Referral tie-ups at key locations for patient flow into hospitals
9 Centres in and around Delhi/NCR by 2009 with a capacity of 1500-1600 beds 23
Second Phase of Expansion NCR
Outside NCR
Max Balaji Hospital – Patparganj Tertiary Care
Max Hospital – Dehradun High-end Secondary Care
n
n
250-300 Inpatient beds with 6 OTs and 1 Cathlab – Before end of 2008 Tower specialties to include: Oncology IVF Orthopaedics & Joint Replacement Neurosciences Cardiac Care Critical Care
n n n n n
100 Inpatient beds – Before end of 2008 Emergency & Trauma care Non–invasive Cardiology Joint Replacement & Orthopaedics MIS All support Specialities
Max Hospital – Saket South Block Tertiary Care n n n
85 Inpatient beds with 2 OTs – April 2009 Obstetrics & Gynaecology Paediatrics 24
Max Healthcare – Outlook Revenue 152 141 126
US $ Million
98 77 54 30 11
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
Cash Breakeven by FY 09 25
Max Healthcare Project Cost and Funding Phase – 1
Equity US$ 95 million
n
Max India – Promoters Current – $37 Mn Future – $23 Mn
n
Warburg Pincus – $31 Mn
n
Other Foreign Investors – $4 Mn
Project Cost US$ 156 million Debt US$ 61 million
n
HDFC – $23 Mn
n
Other Indian Banks and Financial Institutions – $38 Mn
Debt – Equity Ratio: 0.64
Second Phase of Expansion to cost US$ 45 Mn 26
Max New York Life Insurance
www.maxnewyorklife.com 27
Max New York Life Insurance [ MNYL] n
Joint Venture between Max India and New York Life International [ NYL ]
n
NYL, one of Fortune 100 companies provides insurance domain expertise
n
NYL is one of the oldest mutual life insurance company in the US with over $200 billion in assets under management
n
Max India contributes local market understanding and managing regulatory environment
n
Robust business performance – Peak equity investment to be $222 Mn
28
MNYL road map to becoming India’s most admired Life Insurance Company Key Public Messages
VISION
A trusted life insurance specialist Customer centric Financially responsible and strong A great place to work An admired member of the community
MISSION
Key Differentiators
Financial Strength & Security Quality of agents Flexible Products Service Excellence Fair Terms of Business
GOALS
KEY OBJECTIVES
STRATEGIES
Part of top quartile new Life Insurance Companies National Player Brand of FIRST choice Employer of Choice Principal of Choice for Agents
1 Billion $ in Premiums in 10th year IRR–20% plus; Dominate MDRT in India; Profitable by 2008 WHAT – Comprehensive suite of products, competitive pricing, extensive distribution, persistency, customer service excellence, profitable portfolios HOW – Talented People, Professional & Productive Agents, Performance Metrics, Leverage Technology, Teamwork, Customer Centric, Innovative Distribution and Marketing What-When-Who-How-Cost linkage plans at Departmental and Individual levels
INITIATIVES VALUES & BELIEFS
Excellence Caring Integrity Honesty Knowledge Teamwork
Become the most admired Life Insurance Company in India
OPERATING PRINCIPLES
Customer comes first International quality standards Do it right the first time Fact based decisions Bias for result oriented action Financial strength & discipline Direct and open communication Respect Max & NYLI values & parentage Fun at work
METRICS & STANDARDS
Input Output External Internal Absolute Ratios
PERFORMANCE MGMT PROCESS GMPR Ratings TEC/TTR – Templates Primary, Shared and Contributory Balanced scorecard Core, Functional and Leadership Competencies
29
MNYL – Board of Directors Mr. Analjit Singh
Chairman
Mr. B Anantharaman
Joint Managing Director, Max India Limited
Mr. N. C. Singhal Mr. Rajesh Khanna
Warburg Pincus
Mr. Joseph Gilmour Mr. Fred Sievert Mr. Anuroop Tony Singh Mr. Ravi Akhoury Mr. Gary R. Bennett
Chief Executive Officer & Managing Director
Mr. Sunil Sharma
Executive Director & Chief Operating Officer 30
Indian Life Insurance Industry An Opportunity Strong Growth to be driven by…
11.2
Life insurance premium as % of GDP 8.3 8.6
8.9
7.1 7.3
Low Penetration Level
Premium per capita ($) adjusted for PPP 2,337
Taiwan
UK
Hong Kong
Japan
South Korea
France
Singapore
4.1
United States
Malaysia
Better Distribution
3.5 3.6
Australia
n
3.1
Germany
Increasing Awareness
2.5
India
n
1.8 2.0
Thailand
Increasing Per Capita Income
1.3
Brazil
n
6.0
China
n
2,798
2,471
2,079 1,6721,677 1,732
n
1,343
Availability of Multiple Products
883
UK
Hong Kong
Japan
France
Singapore
United States
South Korea
Australia
Germany
Malaysia
Brazil
Increased Life Expectancy
115 143
China
n
88
India
411
Strong GDP growth to further expand the industry potential 31
MNYL’S Strategy to build a Strong Life Insurance Business 1)
Full Suite of products with a focus on protection n Long Tenor products (Average Tenure – 25), Young customer base (Average Age – 34) n Unit Link contributes over 67% of total sales of the Company for the period Jan’06 – Dec’06 rd amongst private players in terms of number of policies sold n Ranks 3 Sold over 1.3 Mn policies since inception
2)
Build best in class agency
3)
n
Productivity higher than the competition
n
Comprehensive in-house training (over 200 trainers)
n
Over 400 hours of training
n
Amongst top global MDRT in 2006 with around 350 agents qualifying for the league
Wide geographic coverage n
132 offices across 94 locations
n
121 new agency offices planned by 2008
n
Multi-level marketing alliances continues to perform well… working at over 300 locations
n
MNYL to focus on developing alternate distribution channels having wide reach and deep-rooted distribution network
n
Partnership with 17 banks, current access covers 450+ branches across 50+ locations 32
MNYL’S Strategy to build a Strong Life Insurance Business 4)
Among the top private Indian life insurers with paid up capital base of $157 Mn
5)
Strong quality orientations to business
6)
n
First life insurer to be awarded the ISO 9000 : 2001 certification
n
6 sigma program underway
n
Balanced scorecard approach
n
Good Audit & Compliance orientation
Strong customer trust and credibility n Balanced investment approach with a very long term view 64% of traditional portfolio consists of long tenor government paper 29% in AA+ and better corporate bonds
7)
n
Equity portfolio performance better than the benchmark*
n
No asterisks in advertising
n
Honest illustration Controlled centrally Sent along with policy
High embedded value / appraisal value creation
*Benchmark Index: CNX 500
33
Protection Oriented, Longer Tenor Life Insurance PRODUCT TYPE
PROPORTION OF POLICIES (%, by number)
Tenure (Years)
Age of Insured (Years)
40
WHOLE LIFE
25
ENDOWMENT
18
TERM
4
DEFERRED ANNUITY
1
17
MONEY BACK
22
12
UNIT LINKED
30
24
26
22
37
42
37
23
35
25 As on Dec 31, 2006
36
MNYL Average
34 MNYL Average
34
Market Position – 2006-07 Insurance Sales (US $ Mn) Company ICICI Prudential Bajaj Allianz HDFC Standard Life SBI Life Max New York Life Aviva Birla Sunlife Tata AIG Reliance Life All Others
Individual New Business Premium (Apr'06-Dec'06) 511 321 168 134 117 5 93 93 80 74
166
Policies (‘000) (Apr'06-Dec'06) 1145 928 284 293 386 3 188 208 283 220 361
Total Private Life Insurers
1757
4296
MS of Private Players (%)
30
22
Source: Insurance Regulatory & Development Authority, Adjusted to include only 10% of Single Premium All Others include: Kotak Life, ING Vysya, Metlife, Shriram Life, Sahara, Bharti AXA, 1 US$ = Rupees 45
35
Established Ourselves amongst the Leading Agency Sales Force Adjusted Single premium
New Business Apr - Dec 2006 (Agency) (US$ Mn)
Agents
Premium per Agent * ($)
Cases per Agent *
358
130,000
306
0.8
209
109,000
213
0.7
17,490
590
92
65,000
158
0.3
67
25,000
297
0.6
62
30,000
232
0.7
46
11,000
466
1.1
45
12,500
404
0.7
39
21,500
202
0.4
36
35,000
114
0.4
33
14,000
260
0.5
15
10,000
169
0.3
93
Rank 3
Rank 1
1.6 Rank 1
* In terms of highest new business premium (Agency) Source: IRDA Journal, media reports and team inputs
36
MNYL Footprint 31 Offices
Wide Reach Established
Dedicated to Rural Business
Punjab HO Chandigarh Dehradun Gurgaon Faridabad Delhi Jaipur Noida Dehradun Meerut Jodhpur Karnal Udaipur Kanpur Lucknow Gwalior
Siliguri Guwhati
Varanasi Ahmedabad Patna Bhopal Rajkot Baroda Asansol Jamshedpur Indore Bhavnagar Kolkata Ranchi Surat Nagpur Vapi Mumbai Kohlapur Bhubaneswar Nasik Aurangabad Raipur Thane Hyderabad Pune
Rajahmundry Visakhapatnam Vijaywada
Panaji Bangalore
Chennai
Actual customer base spread over 200 cities
Cities Own
Offices
87
122
7
10
94
132
Mangalore
Franchisees Coimbatore Madurai Cochin
Overall Presence
Trivandrum
37
Max New York Life Insurance Key Business Drivers a) Sales Value (Annualized first year premium)
Unit US$ Mn
Quarter Ended Dec-06 Dec-05
Year Ended Dec-06 Dec-05
YoY Growth
66.30
36.64
186.47
95.08
96%
b) Average case size
US$
570
369
452
349
30%
c) Case rate per agent per month
No.
1.68
2.29
1.76
1.84
-5%
d) Number of agents
No.
20,987
13,476
56%
e) Net agents added
No.
7,511
6,568
f) Conservation ratio
%
80.06%
80.41%
147.43 109.00 24.78 281.20
75.79 60.36 6.08 142.23
95% 81% 308% 98%
2,205
1,274
g) Gross written premium income First year premium Renewal premium Single premium Total
US$ Mn
h) Paid up Capital
US$ Mn
146.10
117.20
25%
No.
958,229
607,652
58%
8,215
5,227
57%
i) Individual Policies in force j) Sum insured in force
50.05 37.67 12.64 100.35
US$ Mn
23.96 22.05 4.59 50.61
38
Neeman Medical International
www.neeman-medical.com 39
Neeman Medical International Contract Research Organization (CRO) Neeman Medical International is a value added Clinical Research Service Organization. Neeman’s goal is to provide highly competent GCP/ICH compliant Investigators in several geographies, who have access to patients and dedicated Clinical Research Coordinators. This allows Neeman to accelerate patient enrollment and generate high quality data
Neeman Medical International – Service offerings include n
Site Management
n
Project Management
n
Data Management, includes Bio-Statistics and Report Writing
n
Monitoring Services
n
Clinical Trial Material Supply Chain Management Services
40
Neeman Medical International Business Highlights n
6 out of top 10 pharma companies are Neeman’s customers Phase – IV award in the Data Management space from one of the top 3 pharma majors.
n
Discussions underway with pharma majors for making Neeman a preferred service provider Preferred provider relationship with 3 Pharma majors in place
n
Alliances with CROs in Europe for business expansion
n
Client base doubles up from 14 to 28
n
Number of awards swell 177 % from 22 in previous year to 61 up to Dec’ 06
n
Order Book pipeline of over $6.5 Million
n
Network of 600 GCP/ICH Principal Investigators with access to 25,000 beds and 6-8 million patients
n
Impressive operating standards Successfully completed 4th US FDA-GCP audit for highest enrollments Patient retention rate continues to be over 98%
n
Favorable Patent Regulations in India to catalyze exponential growth 41
Neeman – Select List of Partners
42
Max HealthStaff International
www.maxhealthstaff.com 43
Max HealthStaff International Max HealthStaff International Limited is an international healthcare staffing company, founded on world-class quality and service excellence. It is committed to becoming India's leading healthcare staffing company, offering professionals to healthcare institutions in India and abroad. Big Gap in Demand/Supply of Healthcare Resources in US, particularly nurses…projected to increase further US Supply and Demand Projections for Registered Nurses 2000 to 2020
Current Shortage of Nurses: 200,000 Increasing every year – Expected to be over 400,000 by 2008 and 850,000 by 2020 Shortage of allied healthcare staffing resources such as occupational and physical therapists, pharmacists, radiographers etc. estimated to be more than 360,000 by 2008 44
Max HealthStaff International n
First of its kind large scale corporate business initiative in India for providing end to end placement solutions. Has begun placement of nursing staff, will soon expand into other allied healthcare resources
n
Annuity based revenue model with cash inflows expected for periods upto 36 months for each placed candidate
n
6 Sourcing and Training Centers across Delhi, Chandigarh and Kerala Chennai sourcing and training centre to commence operations soon
n
Customer Profile Leading Healthcare staffing companies, including publicly listed companies in US Non-exclusive contracts provides sufficient operational and strategic flexibility to the business
n
50 Nurses already placed in the US – Established proof of concept
n
Over 600 nurses in pipeline… growing rapidly Over 100 NCLEX-RN cleared nurses in the pipeline NCLEX results at 85% – best in the Industry
n
Monthly revenue rate of USD 60k…expected to grow continuously
n
Currently focusing on US, will expand to Middle East shortly 45
Max Speciality Products
46
Max Speciality Products Manufacturer / Supplier of Niche Speciality polymer films. n n n n n
n
(high contribution)
and
High
Barrier
Capture value by producing Value Added products Long term relationship with Blue chip customers in FMCG sector Pioneer in introduction of new products / technology in India Has a footprint in select export markets Industry CAGR of 20%
Generates revenue of $30 Mn and PBT of $2Mn for FY 05-06 Revenue from BOPP business at $28 Mn, grows 7% Revenue from MaxFoils at $2 Mn, grows 42%
n
EBITDA to net sales at 14%
n
Expansion Underway… 3rd Metalliser commissioned ahead of schedule in August’06, currently running at 80% capacity New BOPP capacity expansion – 20,000 TPA in advanced stage of implementation and currently on schedule – to be operational in first quarter FY07-08 Expansion to cost $27 Mn…Funded 66% through debt 47
Thank You
48
Related Documents
Ppt Of Mnyl
May 2020 0
Mnyl Project..
May 2020 12
Mantus Analysis On Mnyl
October 2019 4
Esnipstypes Of Reaction Ppt
July 2020 1
Ppt Of Major Project
November 2019 14